EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of prostacyclin infusion during low flow ischemia in the isolated perfused rat heart






Basic Research in Cardiology 79(2): 125-134

Effect of prostacyclin infusion during low flow ischemia in the isolated perfused rat heart

Although prostacyclin (PGI2) has been shown to exert a protective effect on ischemic hearts its precise mode of action remains obscure. Possible explanations include protection of the high energy phosphate stores (ATP and CP [creatine phosphate]), maintenance of homeostasis with respect to Ca2+ and an antiaggregatory effect. The following experiments were undertaken to investigate these possibilities, using isolated, spontaneously beating rat hearts perfused with Krebs-Henseleit solution. Ischemia was induced at 37.degree. C for 30 min by reducing the flow rate from 10.0 to 0.1 ml/min, and was followed by reperfusion . PGI2 was given as a constant infusion (20 ng/ml). The hearts were frozen and assayed for ATP and CP, or digested in HNO3 and assayed for Ca2+. Peak developed tension was recorded throughout. PGI2 evidently slowed the rate of decline of developed tension during low flow perfusion and hastened the recovery of contractions on reperfusion. These effects could not be accounted for in terms of an improved supply of ATP or CP, or an altered tissue Ca2+. The protective effect of PGI2 on isolated, buffer-perfused hearts may be a reflection of a generalized, but undefined, mechanism of cell preservation which also has been observed in other systems.

(PDF 0-2 workdays service: $29.90)

Accession: 005264732

PMID: 6378173



Related references

Effect of op 2507 a novel prostacyclin analogue on ischemia and reperfusion induced arrhythmias in isolated perfused rat heart. Journal of Molecular & Cellular Cardiology 22(SUPPL 3): S74, 1990

Effect of prostacyclin infusion on active and inactive renin release in the isolated perfused kidney. Life Sciences 31(26): 3031-3036, 1982

Protective effect of nicorandil on postischemic function and tissue adenine nucleotides following a brief period of low-flow global ischemia in the isolated perfused rat heart. Pharmacology 38(4): 205-213, 1989

Beneficial effects of low-flow perfusion resumed early after zero-flow ischemia on myocardial energy metabolism and mechanical function: 31P-NMR study in the isolated perfused rat heart. Tohoku Journal of Experimental Medicine 161(3): 241-250, 1990

Evidence of apoptosis in the crystalloid-perfused isolated rat heart during low-flow ischemia or hypoxia. FASEB Journal 15(4): A509, March 7, 2001

Impact of low-flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart. American Journal of Physiology. Heart and Circulatory Physiology 287(1): H351-H362, 2004

Beneficial effects of low flow perfusion resumed early after zero flow ischemia on myocardial energy metabolism and mechanical function phosphorus 31 nmr study in the isolated perfused rat heart. Tohoku Journal of Experimental Medicine 161(3): 241-250, 1990

Effects of low flow perfusion on the ischemic derangements of myocardial mechanical function and energy metabolism as compared with those of continuous zero flow ischemia phosphorus 31 nmr study in the isolated perfused rat heart. Journal of Molecular & Cellular Cardiology 22(SUPPL 2): S34, 1990

Effect of arachidonic acid perfusion on prostacyclin and thromboxane formation in the isolated perfused guinea pig heart. Naunyn-Schmiedeberg's Archives of Pharmacology 319(SUPPL): R31, 1982

Diltiazem (0.5 mg/l) decreases coronary vascular resistance during reperfusion, but not during low flow ischemia, in the isolated perfused rat heart. Research Communications in Chemical Pathology and Pharmacology 63(1): 3-11, 1989